Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhuri Kalathur

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cellular and Molecular Life Sciences : CMLS|August 24, 2010
Translating tissue-engineered tracheal replacement from bench to bedsideMadhuri Kalathur, Silvia Baiguera, Paolo Macchiarini
Biochemical and Biophysical Research Communications|October 30, 2007
Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cellsBrian T Kawasaki, Tashan Mistree, Elaine M Hurt, et al.
The Prostate|February 11, 2009
Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approachBrian T Kawasaki, Elaine M Hurt, Madhuri Kalathur, et al.
Stem Cell Reports|April 22, 2014
CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivoBenjamin T Spike, Jonathan A Kelber, Evan Booker, et al.
Cell Reports|September 30, 2014
Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunityAlberto Toso, Ajinkya Revandkar, Diletta Di Mitri, et al.
Nature Communications|June 19, 2015
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumoursMadhuri Kalathur, Alberto Toso, Jingjing Chen, et al.
Cancer Cell|March 1, 2024
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cellsManuel Colucci, Sara Zumerle, Silvia Bressan, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cellular and Molecular Life Sciences : CMLS|August 24, 2010
Translating tissue-engineered tracheal replacement from bench to bedsideMadhuri Kalathur, Silvia Baiguera, Paolo Macchiarini
Biochemical and Biophysical Research Communications|October 30, 2007
Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cellsBrian T Kawasaki, Tashan Mistree, Elaine M Hurt, et al.
The Prostate|February 11, 2009
Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approachBrian T Kawasaki, Elaine M Hurt, Madhuri Kalathur, et al.
Stem Cell Reports|April 22, 2014
CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivoBenjamin T Spike, Jonathan A Kelber, Evan Booker, et al.
Cell Reports|September 30, 2014
Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunityAlberto Toso, Ajinkya Revandkar, Diletta Di Mitri, et al.
Nature Communications|June 19, 2015
A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumoursMadhuri Kalathur, Alberto Toso, Jingjing Chen, et al.
Cancer Cell|March 1, 2024
Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cellsManuel Colucci, Sara Zumerle, Silvia Bressan, et al.
Pageof 1